SCHEMBL668605

SCHEMBL668605

CC(=O)SCCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4589722 0.97 TSHR (0.52)
SCHEMBL11441277 0.85 EGLN1 (0.48)
SCHEMBL1820452 0.84 TSHR (0.54)
SCHEMBL9169888 0.82 LMNA (0.52)
SCHEMBL17870866 0.82 CYP1A2 (0.38)
SCHEMBL15135057 0.80 TSHR (0.55)
SCHEMBL3799172 0.80 TSHR (0.55)
SCHEMBL3905981 0.80 TSHR (0.55)
SCHEMBL1647647 0.80 TSHR (0.55)
SCHEMBL3330553 0.80 TSHR (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 540 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382391-A1 METHOD OF MAKING THIOL-FUNCTIONALIZED CELLULOSE NANOCRYSTALS FOR APPLICATIONS IN RUBBER MICHELIN & CIE (FR) 2025-12-18 US claimed
WO-2024091979-A1 CD276 (B7-H3) ANTIBODY-DRUG CONJUGATES BRICKBIO, INC. (US) 2024-05-02 WO claimed
WO-2024007007-A1 THIOL-FUNCTIONALIZED CELLULOSE NANOCRYSTALS FOR APPLICATIONS IN RUBBER COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2024-01-04 WO claimed
WO-2024007017-A1 METHOD OF MAKING THIOL-FUNCTIONALIZED CELLULOSE NANOCRYSTALS FOR APPLICATIONS IN RUBBER COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2024-01-04 WO claimed
CN-115594770-B Construction of rheumatoid arthritis therapeutic vaccine aiming at human TNF alpha molecules 上海惠盾因泰生物科技有限公司 2023-04-07 CN claimed
CN-115594770-A Construction of rheumatoid arthritis therapeutic vaccine aiming at human TNF alpha molecules 上海惠盾因泰生物科技有限公司(CN) 2023-01-13 CN claimed
EP-2249873-B1 CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO A POLYANION FOR THE TREATMENT OF AIDS PASTEUR INSTITUT (FR) 2016-11-16 EP claimed
EP-2478049-B1 A POLYMER SUPPORT UNIV CAPE TOWN (ZA) 2015-02-25 EP claimed
US-20090203842-A1 Macromolecular Conjugates And Processes For Preparing The Same ABBOTT LABORATORIES (US) 2009-08-13 US claimed
EP-1478927-A4 MACROMOLECULAR CONJUGATES AND PROCESSES FOR PREPARING SAME ABBOTT LAB (US) 2008-07-30 EP claimed
EP-1478927-A2 MACROMOLECULAR CONJUGATES AND PROCESSES FOR PREPARING SAME Abbott Laboratories (US) 2004-11-24 EP claimed
WO-2003072017-A2 MACROMOLECULAR CONJUGATES AND PROCESSES FOR PREPARING SAME ABBOTT LABORATORIES (US) 2003-09-04 WO claimed
US-20030149246-A1 Macromolecular conjugates and processes for preparing the same ABBOTT LABORATORIES 2003-08-07 US claimed
WO-2001040306-A9 HUMAN ANTIBODIES AS DETECTION REAGENTS BIOSITE DIAGNOSTICS INC (US) 2002-05-30 WO claimed
JP-61007250-A None JP disclosed
EP-4126833-B1 N-PHENYL-3-MERCAPTOPROPANAMIDE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2026-05-20 EP disclosed
US-12616670-B2 N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2026-05-05 US disclosed
US-4154840-A Antihypertensive pipecolic acid derivatives E. R. SQUIBB & SONS, INC. (US) 1979-05-15 US disclosed
US-4129566-A Derivatives of dehydrocyclicimino acids E. R. SQUIBB & SONS, INC. (US) 1978-12-12 US disclosed
US-4046889-A HYPOTENSIVE AGENTS, ENZYME INHIBITORS, ANGIOTENSIN CONVERSION E. R. SQUIBB & SONS, INC. (US) 1977-09-06 US disclosed